Analysis of influencing factors for acute hemorrhagic apoplexy in pituitary adenomas

陈孝祥,王威,徐蛟天,宋浩,王伟民,邓兴力,乔奕胜,王腾飞,李俊君
DOI: https://doi.org/10.3760/cma.j.cn112050-20201022-00547
2021-01-01
Abstract:Objective:To investigate the influencing factors for acute hemorrhagic apoplexy in pituitary adenoma.Methods:A retrospective analysis was conducted on the clinical data of 319 patients with pituitary adenomas undergoing surgery at Department of Neurosurgery, the First Affiliated Hospital of Kunming Medical University from January 2015 to December 2017. According to the presence or absence of acute hemorrhagic apoplexy in pituitary adenomas, the patients were divided into apoplexy group (60 cases) and non-apoplexy group (259 cases). Univariate and multivariate logistic regression analyses were used to determine whether age, gender, hypertension, diabetes, tumor diameter, tumor type, recurrent tumor and other factors were the influencing factors of acute hemorrhagic apoplexy in pituitary adenomas. Receiver operating characteristic (ROC) curve and the area under the curve (AUC) were used to identify the best cut-off value of risk factors for predicting pituitary adenoma apoplexy.Results:The results of univariate analysis showed that there was no significant difference in gender, age, diabetes or tumor type (all P>0.05), while the differences between the two groups in hypertension, tumor diameter classification and recurrent tumor were statistically significant (all P<0.05). Multivariate logistic regression analysis results showed that hypertension ( OR = 2.270, 95% CI: 1.090-4.728, P=0.029), tumor diameter ( OR =1.087, 95% CI: 1.048-1.126, P<0.001) and recurrent tumor( OR=3.266, 95% CI: 1.343-7.944, P=0.009) were independent risk factors for apoplexy of pituitary adenomas. The ROC curve of tumor diameter predicting pituitary adenoma apoplexy showed that AUC value was 0.718 (95% CI: 0.658-0.779, P<0.001), the best cut-off value was 24.5 mm, the sensitivity was 85%, and the specificity was 45.6%. There were 167 cases with tumor diameter≤25 mm, including 16 cases with acute hemorrhagic apoplexy in pituitary adenoma and 151 cases without apoplexy. There were 152 cases with tumor diameter>25 mm, including 44 cases with pituitary adenoma apoplexy and 108 cases without apoplexy. Tumor diameter>25 mm was a risk factor for acute hemorrhagic apoplexy in pituitary adenomas ( OR = 3.845, 95% CI: 2.062-7.170, P<0.001). Conclusion:Patients with hypertension, tumor diameter>25 mm and tumor recurrence have a high incidence of acute hemorrhagic apoplexy in pituitary adenomas.
What problem does this paper attempt to address?